4.5 Review

Bone mineral density at femoral neck and lumbar spine in adults with type 1 diabetes: a meta-analysis and review of the literature

Journal

OSTEOPOROSIS INTERNATIONAL
Volume 28, Issue 9, Pages 2601-2610

Publisher

SPRINGER LONDON LTD
DOI: 10.1007/s00198-017-4097-x

Keywords

Bone mineral density; Fracture; Meta-analysis; Osteoporosis; Type 1 diabetes

Ask authors/readers for more resources

We performed a meta-analysis to evaluate the femoral neck and lumbar spine bone mineral density (BMD) in adults with type 1 diabetes (T1D) compared with controls. Adults with T1D have modestly lower BMD at femoral neck and lumbar spine than adults without diabetes. Fracture risk is four to sixfold higher in adults with T1D. Since BMD is one of the major contributors for fracture risk, we performed a meta-analysis to evaluate differences in femoral neck and lumbar spine BMD between adults with T1D and controls. MEDLINE, Ovid, and the Cochrane library and abstracts from various scientific meetings were searched. Studies reporting the femoral neck and/or lumbar spine BMD in adults (age > 20 years) with T1D in comparison with people without diabetes were selected. General linear mixed models were used to assess differences in BMD at femoral neck and lumbar spine between subjects with T1D and controls adjusting for age, sex, and dual x-ray absorptiometry (DXA) instruments. Sixteen studies met the inclusion criteria. The femoral neck BMD was modestly lower in adults with T1D compared to controls (-0.055 g/cm(2); 95% CI: -0.065, -0.045). There were no differences in lumbar spine BMD between adults with T1D and controls (0.0062 g/cm(2); 95% CI -0.04, 0.016). However, in a sensitivity analysis, lumbar spine BMD was modestly lower in adults with T1D compared to controls (-0.035 g/cm(2); -0.049, -0.02). Studies using Lunar DXA instruments have reported higher lumbar spine and femoral neck BMD compared to studies using Hologic DXA instruments. Femoral neck and lumbar spine BMD were modestly lower in adults with T1D compared to controls. However, this modest reduction in femoral neck and lumbar spine BMD cannot explain much higher observed fracture risk in adults with T1D.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Letter Endocrinology & Metabolism

Off-label use of sodium glucose co-transporter inhibitors among adults in type 1 diabetes exchange registry

Michael S. Hughes, Ryan Bailey, Peter Calhoun, Viral N. Shah, Sarah K. Lyons, Daniel J. DeSalvo

DIABETES OBESITY & METABOLISM (2022)

Article Endocrinology & Metabolism

Differentiating Diabetic Ketoacidosis and Hyperglycemic Ketosis Due to Cannabis Hyperemesis Syndrome in Adults With Type 1 Diabetes

Halis Kaan Akturk, Janet Snell-Bergeon, Gregory L. Kinney, Anagha Champakanath, Andrew Monte, Viral N. Shah

Summary: The study aimed to differentiate between diabetic ketoacidosis (DKA) and hyperglycemic ketosis due to cannabis hyperemesis syndrome (HK-CHS) in adults with type 1 diabetes. It was found that cannabis users had higher levels of pH and bicarbonate compared to non-users. A positive urine test result for cannabis could be used to predict the occurrence of HK-CHS.

DIABETES CARE (2022)

Article Endocrinology & Metabolism

Continuous Glucose Monitoring Initiation Within First Year of Type 1 Diabetes Diagnosis Is Associated With Improved Glycemic Outcomes: 7-Year Follow-Up Study

Anagha Champakanath, Halis Kaan Akturk, G. Todd Alonso, Janet K. Snell-Bergeon, Viral N. Shah

Summary: Initiating continuous glucose monitoring within the first year of type 1 diabetes diagnosis leads to long-term improvement in A1c levels.

DIABETES CARE (2022)

Article Endocrinology & Metabolism

Impact of Different Types of Data Loss on Optimal Continuous Glucose Monitoring Sampling Duration

Halis Kaan Akturk, Pau Herrero, Nick Oliver, Haley Wise, Emma Eikermann, Janet Snell-Bergeon, Viral N. Shah

Summary: The study suggests that random CGM data loss up to 50% does not significantly affect the optimal sampling duration for CGM metrics, but losing data with longer gaps increases the MdAPE crossing threshold, requiring a longer optimal sampling duration.

DIABETES TECHNOLOGY & THERAPEUTICS (2022)

Review Endocrinology & Metabolism

Effect of divergent continuous glucose monitoring technologies on glycaemic control in type 1 diabetes mellitus: A systematic review and meta-analysis of randomised controlled trials

Mona Elbalshy, Jillian Haszard, Hazel Smith, Sarahmarie Kuroko, Barbara Galland, Nick Oliver, Viral Shah, Martin I. de Bock, Benjamin J. Wheeler

Summary: This systematic review and meta-analysis found that the use of continuous glucose monitoring (CGM) systems had a significant positive impact on glycemic outcomes including HbA1c, time-in-range (TIR), and time-below-range (TBR) in individuals with type 1 diabetes. The results demonstrated that adjunctive CGM and non-adjunctive CGM were particularly effective in improving glycemic control.

DIABETIC MEDICINE (2022)

Article Endocrinology & Metabolism

Efficacy and Safety of Tandem Control IQ Without User-Initiated Boluses in Adults with Uncontrolled Type 1 Diabetes

Halis Kaan Akturk, Janet Snell-Bergeon, Viral N. Shah

Summary: This study investigated the long-term outcomes of the Tandem Control IQ automated insulin delivery system in adults with poorly controlled type 1 diabetes. The results showed that regardless of the users' engagement, the system effectively lowered A1c and improved time in target range without increasing the risk of hypoglycemia.

DIABETES TECHNOLOGY & THERAPEUTICS (2022)

Article Endocrinology & Metabolism

Relationship Between Daytime Versus Nighttime Continuous Glucose Monitoring Metrics with A1C in Adults with Type 1 Diabetes

Viral N. Shah, Halis K. Akturk, Tim Vigers, Laura Pyle, Nick Oliver, David C. Klonoff

Summary: Daytime versus nighttime glycemic control has similar influence on A1C in adults with T1D.

DIABETES TECHNOLOGY & THERAPEUTICS (2023)

Letter Endocrinology & Metabolism

Higher Prevalence of Hypoglycemia and Unsafe Driving Practices in Adults With Type 1 Diabetes

Aria L. Saunders, Cathy Bodine, Janet Snell-Bergeon, Gregory P. Forlenza, Viral N. Shah

DIABETES CARE (2023)

Article Endocrinology & Metabolism

Optimal Sampling Duration for Continuous Glucose Monitoring for the Estimation of Glycemia Risk Index

Viral N. Shah, Casey Sakamoto, Laura Pyle

Summary: This study aimed to evaluate the optimal duration of continuous glucose monitoring (CGM) sampling for estimating glycemia risk index (GRI). CGM data of 225 nonpregnant adults with type 1 diabetes were collected and it was found that longer sampling periods had higher correlation with the 90-day GRI, with 14 days being the optimal duration for estimation.

DIABETES TECHNOLOGY & THERAPEUTICS (2023)

Article Endocrinology & Metabolism

Discordance Between Glucose Management Indicator and Glycated Hemoglobin in People Without Diabetes

Viral N. Shah, Tim Vigers, Laura Pyle, Peter Calhoun, Richard M. Bergenstal

Summary: The use of continuous glucose monitor (CGM) is increasing in healthy individuals without diabetes. However, there is a discrepancy between glucose management indicator (GMI) and glycated hemoglobin (HbA1c) in this population.

DIABETES TECHNOLOGY & THERAPEUTICS (2023)

Article Endocrinology & Metabolism

Changes in the glycaemia risk index and its association with other continuous glucose monitoring metrics after initiation of an automated insulin delivery system in adults with type 1 diabetes

Kagan E. Karakus, Viral N. Shah, David Klonoff, Halis K. Akturk

Summary: This study aimed to evaluate the glycaemia risk index (GRI) and its association with other continuous glucose monitoring (CGM) metrics after initiation of an automated insulin delivery (AID) system. The study found that GRI was highly correlated with various CGM metrics above target range, but not below.

DIABETES OBESITY & METABOLISM (2023)

Article Endocrinology & Metabolism

Pharmacokinetic similarity of switching SAR341402 insulin aspart biosimilar and NovoLog insulin aspart versus continuous use of NovoLog in adults with type 1 diabetes: The GEMELLI X trial

Viral N. Shah, Amer Al-Karadsheh, Cathy Barnes, Jose Mandry, Samer Nakhle, Karin Wernicke-Panten, Daniel Kramer, Wolfgang Schmider, Suzanne Pierre, Lenore Teichert, Baerbel Rotthaeuser, Bhaswati Mukherjee, Timothy S. Bailey

Summary: This study assessed the impact of switching frequency between SAR341402 biosimilar insulin aspart (SAR-Asp) and insulin aspart reference product (NN-Asp) on the pharmacokinetic exposure in adults with type 1 diabetes. The results showed no significant differences in pharmacokinetic exposure between the switching and non-switching groups, supporting the interchangeability of these two insulin aspart products.

DIABETES OBESITY & METABOLISM (2023)

Article Endocrinology & Metabolism

Limitations of Reporting Time Below Range as a Percentage

Viral N. Shah

Summary: Continuous glucose monitoring (CGM) metrics such as time in range and time below range (TBR) are recommended alongside glycated hemoglobin (A1c) for diabetes care optimization. However, expressing TBR as an integer percentage and rounding-off numerical values may lead to misleading interpretations. This article aims to generate more discussion on reporting TBR in ways that are clinically impactful for diabetes patients, healthcare providers, regulatory agencies, and payers in predicting severe hypoglycemic events.

DIABETES TECHNOLOGY & THERAPEUTICS (2023)

Article Endocrinology & Metabolism

Bone Structure and Turnover in Postmenopausal Women With Long-Standing Type 1 Diabetes

Viral N. Shah, Shijing Qui, Jason Stoneback, Lubna Qamar, Virginia L. Ferguson, Wendy M. Kohrt, Janet K. Snell-Bergeon, Sudhaker D. Rao

Summary: This study investigated bone structure and turnover in postmenopausal women with type 1 diabetes (T1D). The results showed that T1D may affect bone turnover, mainly bone formation, without significantly affecting bone structure.

JBMR PLUS (2023)

Article Endocrinology & Metabolism

Differentiating Diabetic Ketoacidosis and Hyperglycemic Ketosis Due to Cannabis Hyperemesis Syndrome in Adults With Type 1 Diabetes

Halis Kaan Akturk, Janet Snell-Bergeon, Gregory L. Kinney, Anagha Champakanath, Andrew Monte, Viral N. Shah

Summary: The study found that cannabis users had significantly higher pH and bicarbonate levels compared to non-users, and the accuracy of predicting HK-CHS with a positive cannabis urine test result was high.

DIABETES CARE (2022)

No Data Available